close

Enter

Log in using OpenID

Insomnia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embedDownload
Insomnia Treatment Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2029
Global insomnia treatment market to value over USD 5.8 Billion by 2029 end and
register a CAGR of over 5.2% from 2019 to 2029.
The growing cases of insomnia worldwide due to rising stress levels has led to the
growth of this market. With rising geriatric population coupled with awareness about
numerous therapies and treatments in the market, support and propel the market’s
growth.
With advancements in technology and invention of better, efficient, new therapies
providing quick, positive results, the public is more open to accepting such cures.
Thus the increase in the launch of novel products such as Merck & Co.’s Belsomra is
projected to fuel high demand. Moreover, the availability of multiple generics is
expected to boost the insomnia therapeutics market over the forecast period.
Lemborexant, a novel Orexin Receptor Antagonist (ORA) by Eisai is expected to be
launched in the near future, which may promote growth.
With new products and technology employed the market is estimated to soar
unboundedly. Additionally, quite a few medical devices have been approved in the
recent years such as EBB Insomnia Therapy, Fisher Wallace Stimulator, and AlphaStim AID, which are expected to have higher penetration due to favourable
reimbursement policies and adoption of the device-drug combination therapies for
treating insomnia.
North America was leading the insomnia therapeutics market and accounted for a
major revenue share. Favourable reimbursement policies will further promote
revenue growth.
North America is followed by the Asia Pacific, which is poised to grow at healthy
CAGR. Emerging economies such as India, China, and Indonesia have been using
generics and branded generics due to the economic pricing of generic alternatives.
Asia Pacific is anticipated to witness lucrative growth over the forecast period with a
high CAGR.
The global insomnia therapeutics market is highly fragmented with several
manufacturers offering generics. Major market players are Takeda Pharmaceutical
Company Ltd.; Vanda Pharmaceuticals; Merck & Co., Inc.; Pfizer Inc.; Teva
Pharmaceutical Industries Ltd.; Mylan N.V.; Sumitomo Dainippon Pharma Co., Ltd;
Sanofi; Paratek Pharmaceuticals Inc.; and Ebb Therapeutics. Major strategies are
novel drug development and technological advances in medical devices are expected
to boost competition in this market.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=258&page=requestsample
Global Insomnia Treatment Market: Segmentation
By Drug Type
• OTC Drugs
• OTC Sleep Aids
• OTC Sleep Supplements
• Prescription Drugs
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce
• Drug Stores
• Others
By Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=258&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth
Objectives of the Study:
• To provide an exhaustive analysis on the global insomnia treatment market by
drug type, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East.
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Market Introduction


Market Definition
Market Taxonomy
2. Executive Summary


Market Overview
Market Analysis
3. Market Dynamics





Macro-Economic Factors
Drivers
Restraints
Opportunity Analysis
Trends
4. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Drug Type, 2014–
2018
OTC Drugs


OTC Sleep Aids
OTC Sleep Supplements
Prescription Drugs
Market Size (US$ Mn) Forecast By Drug Type, 2019–2029
5. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Distribution Channel,
2014–2018




Hospital Pharmacies
Retail Pharmacies
e commerce
Drug Stores

Others
6. North America Insomnia Treatment Market Analysis 2014–2018 and Forecast
2019–2029





Introduction
Regional Market Trends
U.S.
Canada
Market Size (US$ Mn) Forecast By Country, 2019–2029
7. Latin America Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–
2029







Introduction
Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
Argentina
Brazil
Mexico
Rest of Latin America
Market Size (US$ Mn) Forecast By Country, 2019–2029
8. Europe Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029










Introduction
Germany
U.K.
France
Italy
Spain
Russia
Poland
Rest of Europe
Market Size (US$ Mn) Forecast By Country, 2019–2029
9. Asia Pacific Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–
2029






Introduction
Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
China
Japan
India
Australia and New Zealand



ASEAN
Rest of Asia Pacific
Market Size (US$ Mn) Forecast By Country, 2019–2029
10. Middle East & Africa Insomnia Treatment Market Analysis 2014–2018 and
Forecast 2019–2029






Introduction
Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
GCC Countries
South Africa
Rest of MEA
Market Size (US$ Mn) Forecast By Country, 2019–2029
11. Competition Analysis










Merck & Co. Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Sunovion Pharmaceuticals, Inc.
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
shubhambhosale1911
Document
Category
Uncategorized
Views
1
File Size
29 KB
Tags
size, trends, 2029, treatment, market, growth, forecasts, opportunities, share, industry, global, insomnia, 2019
1/--pages
Report inappropriate content